Dataset opportunity
Huskmedical — 公共采购数据集机会
Huskmedical 持有的中等规模公共采购数据集，可用于招标情报和文档情报。
Score
65.8
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
收购
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球采购分析市场 = 2026 年为 71.1 亿美元，复合年增长率为 23.85%。
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-07-23
Husk Medical B.V. — Netherlands – Medical consumables – Sensoren en patiëntkabels t.b.v. diepte van anesthesie (DoA-) monitoring
ted.europa.eu ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- ✨Signal
专注于“有价值的合作伙伴关系”和供应链优化
source ↗
Profile
Dataset profile
Type
公共采购数据集
Modality
文本
Sector
医疗保健
Volume
中等
Freshness
定期
Rarity
高（专有）
Accessibility
受限
Legal
公司所有 — 许可权待澄清 · PII/受监管
Buyer persona
GovTech 和采购情报供应商
Huskmedical 拥有文本模态的公共采购数据集，其中包含详细的 `industrial_data`、`procurement` 记录和 `transaction_data`。这些细粒度证据直接适用于招标情报用例，使人工智能能够分析医院采购模式、医疗供应链动态以及 NRFit 和 DeltaVen 等特定第三方品牌的竞争性定价。
全球采购分析市场截至 2026 年的价值为71.1 亿美元，预计复合年增长率为 23.85%，其中医疗保健领域是其主要增长驱动力。[1] 虽然必须应对潜在的保密条款、第三方数据所有权验证和 GDPR 敏感性等访问复杂性，但该类有价值数据的市场增长和高需求使得协商访问成为一项有价值的战略投资。⚠ 尽职调查（有价值的数据，协商访问权）：数据涉及医疗供应链和医院采购，可能包含保密条款；需要验证特定第三方品牌（例如 NRFit、DeltaVen）的使用数据所有权；如果销售记录与特定从业者或小型诊所相关，可能存在 GDPR 敏感性 · 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Huskmedical 持有一个专有数据集，详细说明了广泛的医疗保健采购，涵盖了从诊断到手术室的各种临床部门，其中包含产品级别的消耗数据。对于寻求为下一代招标情报平台提供支持的 GovTech 和采购情报供应商而言，这是一项高价值资产。在全球采购分析市场以超过 23% 的复合年增长率增长的情况下，该数据集提供了一个难得的机会来模拟真实的医疗设备采购和供应链动态，从而提供显著的竞争优势。
See dimension details ↓- Dataset Specificity90
主导的“采购”，医疗保健行业，3 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
定期
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
适用于招标情报
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand92
人工智能买家需求异常高，这得益于采购分析市场的快速扩张，预计该市场将以 23.85% 的复合年增长率增长，因为公司寻求数据驱动的供应链和支出洞察。[1]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
中等难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 种证据类型，3 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License70
所有权=公司所有，许可=权利不明确
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 个数据需求信号（1 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus70
盈余=中等，1 个近期外部信号 — 超出已货币化范围的专有数据
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit92
✓ 良好目标 — Husk Medical 是医疗供应链合作伙伴，销售实体医疗耗材并利用数据优化其自身物流，使其成为一个拥有休眠数据的良好目标。问题：初步线索信息“公共采购数据集机会”具有误导性；公司的核心业务是销售实体医疗商品，而不是数据；公司将其运营描述为“数据驱动”以实现自身供应链卓越，这是有价值的专有数据的来源，而不是其产品
- Deep Qualification60
⚠ 需要审查 — Husk Medical 是一家医疗用品分销商，其作为数据驱动的供应链合作伙伴的商业模式非常适合生成指定采购数据集。然而，其地理区域与其专注于波兰的细分市场不符，并且缺乏可访问的法律文件使得数据所有权和许可权无法验证。[实体不持有细分市场的特征数据：公司列出的运营国家（荷兰、比利时/卢森堡、德国、爱尔兰、英国）不包括波兰，而波兰是该细分市场的地理焦点。[10]]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Procurement / tenders
文本证据证实了数据集的范围涵盖了从诊断到手术室的各种临床部门，提供了训练细致的医疗保健招标分析模型所需的丰富上下文数据。
Industrial data
这些时间序列数据表明了特定医疗设备产品线的专有吞吐量信息，提供了公共采购记录中无法获得的细粒度供应链情报。
Transaction data
表格数据证实了与医院和诊所的全球B2B 交易历史，提供了验证采购模型所必需的购买行为的地面真实层。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Huskmedical Public Procurement — a Moderate public procurement dataset (Text modality) in the healthcare domain. Primary AI use-case: Tender Intelligence. Market signal: Global Procurement Analytics market = $7.11 billion in 2026, CAGR 23.85% (source: Mordor Intelligence) [1]. Investment score 65.8/100 (confidence 0.49). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Discovery Acquisition — 工业运营数据集机会
View opportunity →工业Cvgeophysics — 工业运营数据集机会
View opportunity →工业Fon Energy — 维护日志数据集机会
View opportunity →